PharmacoEconomics & Outcomes News

, Volume 817, Issue 1, pp 38–38 | Cite as

Weight loss more cost effective than pioglitazone for NAFLD

Clinical study


  1. Chongmelaxme B, et al. Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand. PharmacoEconomics : 15 Nov 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations